Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Active not recruiting × Prostatic Neoplasms × Electroporation × Clear all

Phase

Status

Unknown 3 Recruiting 3 Completed 2 Withdrawn 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 1

Interventions

enzalutamide 31 Prednisone 27 Abiraterone Acetate 27 apalutamide 26 Radiotherapy 26 Magnetic Resonance Spectroscopy 26 Leuprolide 22 Androgen Antagonists 21 Radiosurgery 20 Docetaxel 18 darolutamide 16 acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 15 Gonadotropin-Releasing Hormone 15 Goserelin 13 pembrolizumab 12 gallium 68 PSMA-11 12 bicalutamide 12 Specimen Handling 12 abiraterone 11 Radiotherapy, Intensity-Modulated 11 Radiation 11 Pluvicto 11 Carboplatin 11 2-(3-(1-carboxy-5-((6-fluoropyridine-3-carbonyl)amino)pentyl)ureido)pentanedioic acid 9 relugolix 8 olaparib 8 luprolide acetate gel depot 8 Triptorelin Pamoate 8 Standard of Care 8 Nivolumab 8

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05345444 2026-03-25

RTIRE

Weill Medical College of Cornell University

Phase NA Active not recruiting

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡